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Abstract: Annexin A13 is the founder member of the 
vertebrate family of annexins, which are comprised of a 
tetrad of unique conserved domains responsible for cal-
cium-dependent binding to membranes. Its expression is 
restricted to epithelial intestinal and kidney cells. Alterna-
tive splicing in the N-terminal region generates two iso-
forms, A13a and A13b, differing in a deletion of 41 residues 
in the former. We have confirmed the expression of both 
isoforms in human colon adenocarcinoma cells at the 
mRNA and protein levels. We have cloned, expressed, and 
purified human annexin A13a for the first time to analyze 
its structural characteristics. Its secondary structure and 
thermal stability differs greatly from the A13b isoform. 
The only tryptophan residue (Trp186) is buried in the pro-
tein core in the absence of calcium but is exposed to the 
solvent after calcium binding even though circular dichro-
ism spectra are quite similar. Non-myristoylated annexin 
A13a binds in a calcium-dependent manner to acidic 
phospholipids but not to neutral or raft-like liposomes. 
Calcium requirements for binding to phosphatidylserine 
are around 6-fold lower than those required by the A13b 
isoform. This fact could account for the different subcel-
lular localization of both annexins as binding to baso-
lateral membranes seems to be calcium-dependent and 
myristoylation-independent.
Keywords: annexin; calcium binding; circular dichroism 
spectroscopy; fluorescence emission spectroscopy; phos-
pholipid binding; thermal stability.
Introduction
Annexins are a widely distributed multigene super family 
characterized by their ability to interact with biologi-
cal membranes in a calcium dependent manner (Raynal 
and Pollard, 1994; Swairjo and Seaton, 1994; Gerke and 
Moss, 2002; Lizarbe et al., 2013). These proteins present a 
marked preference for interaction with acid phospholip-
ids, mainly phosphatidylserine (PS), but differences are 
found among them regarding lipid composition, structure 
preferences and calcium requirements for the interaction. 
They are expressed by all living organisms, from protists 
to higher eukaryotes and plants, but with the exception 
of bacteria. However, the group of Fernandez and Morgan 
first reported the presence of a gene coding for a single 
domain annexin in the bacteria Cytophaga hutchinsonii, 
although the protein is not expressed (Morgan et al., 2006) 
and a broader survey of bacterial genomes has identified 
around 30 annexin homologs, including single-domain 
and multi-domain annexins in 17 bacterial species 
(Kodavali et al., 2014).
The annexin core shows a characteristic tetrad struc-
ture of homologous internal repeats (eight in annexin 
A6), domains of around 70 amino acids, with the overall 
shape of a slightly bent ring surrounding a central hydro-
philic pore (Liemann and Huber, 1997). Calcium- and 
phospholipid-binding sites are located on the convex 
side while the N-terminus links domains I and IV on 
the concave side (Lizarbe et  al., 2013). The N-terminus 
region shows great variability in length and amino acid 
sequence and it greatly influences protein stability and 
specific functions of annexins (Turnay et  al., 2003a,b). 
Despite their gross structural similarity, annexins have 
diverged significantly in terms of their gene regulation, 
tissue-specific expression patterns, subcellular locali-
zation of different isoforms, and features peculiar to 
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individual annexins. Members of this family are involved 
in a wide range of intra and extracellular biological pro-
cesses, most of them directly related with the conserved 
ability to bind to phospholipid bilayers. These functions 
involve membrane trafficking, exocytosis, endocyto-
sis, membrane-cytoskeleton anchorage, regulation of 
membrane protein activities, membrane repair, calcium 
channel activity and regulation, and signal transduction 
(Raynal and Pollard, 1994; Swairjo and Seaton, 1994; 
Gerke and Moss, 2002; Lizarbe et al., 2013; Bouter et al., 
2015). Even though annexins are mainly intracellular 
proteins and lack signal sequences for secretion, some 
of them (i.e. A1, A2 or A5) have been detected extra-
cellularly, either secreted or attached to the outer mem-
brane, where they may also exert some activities such as 
inhibition of blood coagulation, inhibition of neutrophil 
migration, interaction with extracellular proteins such as 
collagen or serum proteases, or even act as docking point 
for certain viruses. Annexins are also involved in a wide 
variety of pathological conditions ranging from cancer 
(i.e. annexins A2, A4 and several others) ( Mussunoor 
and Murray, 2008; Wang and Lin, 2014; Wei et al., 2015), 
resistance to chemotherapy [annexin A13 (AnxA13)] 
(Reiske et al., 2010) to inflammation and autoimmunity 
(i.e. annexin A1, A2 or A5) (D’Acquisto et al., 2013; Misasi 
et al., 2015).
AnxA13 is considered as the founder member of the 
vertebrate family of annexins and the prototype for con-
served evolutionary properties of this superfamily of pro-
teins (Morgan et al., 1998; Iglesias et al., 2002). Alternative 
splicing of exon 2 yields two different isoforms, a long 
one (AnxA13b) and a short one whose mRNA lacks exon 2 
that codes for a 41 amino acid cassette in the N-terminus 
(AnxA13a), which confers differential properties to these 
proteins (Lecat et al., 2000). Most vertebrate annexins are 
widely spread in all tissues although a few of them may be 
preferentially expressed in specific ones, as annexin A4 
in epithelial cell-rich tissues (Kaetzel et al., 1989; Fiedler 
et al., 1995). Both AnxA13 isoforms have a specific tissue 
expression and they are only detected in gut and kidney 
(Wice and Gordon, 1992; Fiedler et al., 1995). Moreover, a 
unique characteristic among vertebrate annexins is that 
they are myristoylated in vivo in their N-terminal glycine 
residue although the recognition sites for N-myristoyl-
transferase (NMT) differ due to the loss of 41-residue 
cassette in AnxA13a. The predicted 17-residue sequences 
(Maurer-Stroh et al., 2002) for both AnxA13 isoforms are 
shown in Supplementary Figure 1. Although AnxA13 is an 
interesting target protein regarding enterocyte differentia-
tion, its structure and function has been scarcely studied. 
In fact, the only structural/functional characterization of 
the recombinant long isoform has been carried out by our 
group (Turnay et al., 2005).
AnxA13a isoform was the first one discovered in HT-29 
human colorectal carcinoma cells growing in the absence 
of glucose and using inosine as carbon source (Wice and 
Gordon, 1992), suggesting that AnxA13a could be a gene 
product involved in the specific differentiation process 
of colonocytes. However, no further reports have dealt 
with this isoform in human cells or tissues. Subcellular 
localization and potential function of both isoforms have 
been reported in epithelial polarized Madin-Darby Canine 
Kidney (MDCK) type II cells transfected with recombi-
nant adenoviruses expressing AnxA13a, AnxA13b and 
non-myristoylated mutants. One of the most interesting 
differences between both AnxA13 isoforms is their dif-
ferent distribution in polarized epithelial cells. It has 
been described that AnxA13b is only located in the apical 
membranes whereas AnxA13a is distributed between the 
two plasma membrane domains but preferentially in the 
basolateral one (Lecat et al., 2000). The potential role of 
AnxA13b in apical transport of raft-containing vesicles 
from the trans-Golgi network has been also suggested 
(Fiedler et al., 1995; Lafont et al., 1998) as well as its inter-
action with the C2-domain of Nedd4 (ubiquitin protein 
ligase) directing it to the apical membrane (Plant et  al., 
2000). The short isoform is also partially associated to 
rafts in the apical membranes and, like AnxA13b, stimu-
lates apical transport of influenza virus hemagglutinin. 
However, only AnxA13a seems to be involved in basolat-
eral vesicle delivery (Lecat et al., 2000).
Immunolabeling of thin frozen sections of intestinal 
tissue has allowed the subcellular localization of different 
types of annexins, including AnxA2 (basolateral plasma 
membranes and the terminal web), AnxA4 (basolateral 
membranes) and AnxA13 (apical and basolateral mem-
branes). Antibodies used for the localization of AnxA13 
recognized both isoforms. Moreover, Western blot of intes-
tinal tissue revealed the expression of both AnxA13 iso-
forms (Massey-Harroche et  al., 1998; Massey-Harroche, 
2000). Why do these cells require the expression of both 
the long and short forms of this annexin? In order to clarify 
this topic, we first need to characterize the structure and 
in vitro characteristics of both proteins. We have previously 
analyzed recombinant AnxA13b, but there is no struc-
tural or functional information regarding AnxA13a. Thus, 
in view of this lack of information supporting the physi-
ological role of this annexin, we have cloned, expressed 
and purified human AnxA13a to investigate its structural 
properties and phospholipid-binding ability that could 
yield information to begin understanding the requirement 
of both isoforms in epithelial gastrointestinal cells.
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Results
Expression of AnxA13a in human colorectal 
carcinoma cells
There is only one report on the expression of AnxA13a 
in human cells. The original report from 1992 (Wice and 
Gordon, 1992) described the expression of AnxA13a 
mRNA in HT-29 cells. Thus we used these cells together 
with Caco-2 cells to confirm the expression not only of 
this isoform but also the larger one, AnxA13b. We used 
specific primers to distinguish between isoforms ‘a’ and 
‘b’ as well as a primer pair able to amplify both (Supple-
mentary Figure  1). RT-PCR confirmed the expression of 
mRNA from both annexin isoforms in HT-29 and Caco-2 
cells without showing significant differences in the 
expression between cell lines (Figure 1A). The only signif-
icant difference was found in the mRNA relative expres-
sion of the isoforms in Caco-2 cells (but not in HT-29 cells), 
where the AnxA13b/AnxA13a ratio was 2.2 ± 0.4 (p < 0.05). 
The expression of the protein isoforms was also verified 
by Western blot (Figure 1B). Again, no significant differ-
ences in the isoform ratio were detected in exponentially 
growing HT-29 cells whereas AnxA13b protein levels were 
2-fold higher (p < 0.05) than those from AnxA13a in Caco-2 
cells.
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Figure 1: Expression of AnxA13 isoforms in human colorectal carci-
noma cells.
(A) RT-PCR analysis of AnxA13 isoforms using specific (A13a and 
A13b) and generic (A13a+b) primer pairs. GAPDH mRNA expression 
was used as control. Expected band sizes are: GAPDH, 226 bp; A13a, 
204 bp; A13b, 201 bp; A13a+b, 216 and 339 bp for isoform ‘a’ and 
‘b’, respectively. (B) Western blot analysis of total cell homogenates 
from exponentially growing Caco-2 (C) and HT-29 (H) cells using a 
polyclonal antibody raised against AnxA13b. Vinculin expression is 
shown as control of even protein loading.
Circular dichroism analysis and thermal 
stability of purified recombinant AnxA13a
Due to the lack of information regarding the short 
annexin A13 isoform, and taking into account the 
reported different cellular behavior of both isoforms, we 
cloned, expressed in E. coli, and purified AnxA13a (Sup-
plementary Figure 2). Circular dichroism (CD) spectrum 
of AnxA13a at 20°C in the far-UV region in the absence 
of calcium is shown in Figure 2A (A13a; solid line). The 
shape of the spectrum reflects a high α-helical percent-
age in the secondary structure of the protein, with two 
minima at 208 and 221  nm with molar ellipticities of 
−20.994 and −20.775 degrees·cm2·dmol−1, respectively. 
Accordingly, the CCA prediction indicates that the main 
contributions to the secondary structure are α-helix 
(80%), random coil (8%), and turns (12%) in good agree-
ment with the secondary structure of the protein core of 
other annexins whose 3D structure is already known, 
and with the model that we proposed previously for the 
protein core of isoform AnxA13b (Turnay et  al., 2005). 
The CD spectrum of AnxA13a significantly differs from 
that of the A13b isoform (Figure 2A) due to the random 
coil structure of the long N-terminal domain present in 
the A13b isoform which is absent in A13a. It also differs 
from the spectrum of AnxA5 (Figure 2A; A5) even though 
the percentages of secondary structure in the protein 
core are quite similar and both annexins present a very 
short N-terminus.
The addition of CaCl2 up to 85 mm induced only 
a slight modification in the CD spectrum of AnxA13a 
(Figure 2A, dashed line). Secondary structure prediction 
did not reveal significant changes in the percentage of 
α-helix and the ratio [θ]221/[θ]208 was in both cases almost 
identical and close to 1, indicating that no variations in 
helix length were induced after saturation with calcium. 
The long AnxA13b isoform behaved in a similar way but 
showing a slight increase in α-helical content and helix 
length (Turnay et al., 2005) smaller than that detected in 
annexins A5 and A11 (Turnay et al., 2002; Lecona et al., 
2003). Conversely, binding of calcium is accompanied 
by a hyperbolic increase in the melting temperature (Tm) 
from 50.0 ± 0.5°C in the absence of calcium (1 mm EGTA) 
up to 60.9 ± 0.4°C when saturated with this cation (85 mm 
CaCl2), with a midpoint around 20 mm (Figure 2B, inset). 
This increase is specific for calcium, as it could not be 
reproduced by addition of MgCl2 or NaCl at an equivalent 
ionic strength (Figure 2B, inset). The study of calcium 
binding in the absence of phospholipids requires the use 
of millimolar concentrations of CaCl2, as it is well known 
that the affinity of annexins for this cation is around three 
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Figure 2: Far-UV circular dichroism spectra of AnxA13a.
(A) Far-UV CD spectra of AnxA13a (0.3 mg/ml) without calcium (solid line) and in the presence of 85 mm CaCl2 (dashed line) at 20°C are 
shown in comparison with spectra from human annexin A5 and the A13b isoform. Spectra were registered in 20 mm Hepes, pH 7.4, contain-
ing 0.1 m NaCl. Each spectrum represents the average of six scans. (B) Influence of calcium binding on the thermal stability of annexin 
A13a. The figure shows only representative melting curves of AnxA13a in the absence (1 mm EGTA) and in the presence of increasing CaCl2 
concentrations (up to 85 mm) in 20 mm Hepes, pH 7.4, and 0.1 m NaCl. Melting points were determined from the inflection point of the 
first derivative of the smoothed melting curves using the Standard Analysis software from Jasco and data represent the means ± SD of at 
least two independent determinations at each CaCl2 concentration. The inset shows the dependence of the Tm on CaCl2 concentration (open 
circles). Black symbols show the effect of 85 mm MgCl2 (square) or NaCl (triangle) at a concentration to obtain a protein solution with ionic 
strength equivalent to buffer containing 85 mm CaCl2.
orders of magnitude lower under these conditions (Ayala-
Sanmartin et  al., 2000; Turnay et  al., 2002). Thermal 
denaturation was followed by recording the molar elliptic-
ity at 208 nm as a function of the temperature, as the main 
structural component of AnxA13a is α-helix. The melting 
curves showed a highly co-operative transition disre-
garding the calcium concentration used and the unfold-
ing was always irreversible, as cooling of the denatured 
preparations did not recover the molar ellipticity values 
(not shown).
Fluorescence emission analysis
In order to analyze whether the tertiary structure sur-
rounding the only Trp186 residue in AnxA13a is modi-
fied by calcium binding, we first registered fluorescence 
emission spectra with an excitation wavelength of 
295 nm (Figure 3A) in the presence of different calcium 
concentrations, as the position of the emission maximum 
gives information regarding the exposition degree of the 
Trp residue. In the absence of calcium, the maximum 
is found at 320  nm but a significant red shift towards 
344  nm is observed upon calcium binding that must 
arise from an increase in exposure to the polar solvent. 
Trp186 emission follows a hyperbolic dependence on 
calcium concentration in the ratio between intensities 
at 344 and 320 nm and in the position of the maximum 
(Figure 3B) with midpoint effects at 2.5 mm and 1.1 mm, 
respectively (which could be considered roughly as 
apparent dissociation constants), and are almost identi-
cal to those obtained for the long isoform (2.7 mm and 
1.0 mm, respectively) (Turnay et  al., 2005). Addition of 
75 mm MgCl2 only induced a slight change in the emis-
sion spectra with a 2 nm red-shift in the maximum and a 
minimal variation in the F344/F320 intensity ratio, showing 
that the changes in the fluorescence emission spectra of 
Trp186 are calcium-specific. Moreover, we recorded Ray-
leigh scattering as a function of calcium or magnesium 
concentration and did not find significant variations 
indicating that these variations are not due to protein 
aggregation (Figure 3B, lower panel).
Acrylamide quenching of tryptophan 
emission
The exposure degree of Trp186 to the solvent can be 
quantified by means of dynamic fluorescence emis-
sion quenching experiments using acrylamide, which 
presents low accessibility to buried residues. The study 
was carried out in the absence (Figure 3C, continuous 
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Figure 3: Fluorescence emission spectra of AnxA13a after calcium binding and acrylamide quenching of tryptophan emission.
(A) Emission spectra at 295 nm excitation wavelength in the absence of calcium (1 mm EGTA) or at increasing CaCl2 concentrations were reg-
istered at 20°C using a protein concentration of 0.2 mg/ml. Only spectra at representative calcium concentrations are shown. Fluorescence 
is expressed in arbitrary units (a.u.). (B) Variations in the F344/F320 fluorescence intensity ratio of Trp186 and in the position of its emission 
maximum (inset) with calcium concentration (open circle, MgCl2 instead of CaCl2). The lower panel represents the Rayleigh scattering at 
295 nm (RS295) of buffer (up triangles) or AnxA13a at different calcium (black circles) or magnesium (open circle) concentrations. Data are 
normalized versus RS295 value from the AnxA13a preparation in the absence of calcium (EGTA 1 mm). (C) Fluorescence emission (λex = 295 nm) 
at 20°C of Trp186 in AnxA13a (0.2 mg/ml) was quenched by sequential addition of a concentrated acrylamide stock solution up to 170 mm. 
Spectra in the absence of calcium (1 mm EGTA, continuous lines) and in the presence of 75 mm CaCl2 (dashed lines) are shown. (D) Fluores-
cence intensity at 320 nm (absence of calcium; filled circles) or at 344 nm (75 mm CaCl2; open circles) was determined and the data were 
plotted against acrylamide concentration according to the Stern-Volmer equation. Stern-Volmer constants (KSV) are shown.
lines) and in the presence of 75 mm CaCl2 (dashed lines) 
through analysis of the sensibility of fluorescence emis-
sion (λex = 295 nm) to acrylamide quenching. Figure 3D 
shows the Stern-Volmer plots (F0 /F) using acrylamide 
concentrations that do not involve inner-filter effects 
(up to 170 mm). The decrease in intensity observed in the 
spectra in both cases, without altering the position of 
the maximum, confirmed the accessibility of acrylamide 
to the unique Trp residue of AnxA13a. The fluorescence 
emission data at the corresponding maximum (320 or 
344 nm) were adjusted according to the Stern-Volmer 
equation as a function of acrylamide concentration, 
yielding quenching constants (KSV) of 2.15 and 12.84 m−1 
in the absence (1 mm EGTA) or presence of 75 mm CaCl2, 
respectively.
Phospholipid binding
The interaction of AnxA13a with phospholipid vesicles 
was studied by ultracentrifugation after incubation of 
the protein with an excess of large unilamellar vesicles 
(400 nm in diameter) in the absence (1 mm EGTA) or pres-
ence of 150 μm CaCl2 (Figure 4A). The vesicle pellets and 
supernatants were analyzed separately by SDS-PAGE. In 
the absence of phospholipid vesicles, protein sedimen-
tation is minimal disregarding the absence of presence 
of calcium (Figure 4A, upper panel). The same effect is 
observed when liposomes with different composition 
are included in the absence of calcium; no interaction 
is detected between recombinant AnxA13a and vesi-
cles. When calcium was added at 150 μm, recombinant 
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Figure 4: Binding of AnxA13a to liposomes with different lipid 
composition.
(A) The binding of recombinant AnxA13a to 400 nm unilamel-
lar liposomes with different lipid composition [PS, PG, PC and 
PC:sphingomyelin:cholesterol in the ratio 1 : 1 : 1 (raft-like)] was 
performed by ultracentrifugation in the absence of calcium (1 mm 
EGTA; −Ca2+) or in the presence of 150 μm CaCl2 (+Ca2+) with a lipid/
protein molar ratio of 800 : 1. AnxA13a in the supernatants (S) and 
in the pellets (P) was analyzed by SDS-PAGE followed by Coomassie 
blue staining; representative gels are given. (B, C) The influence 
of calcium concentration on the binding of AnxA13a to 400 nm 
PS vesicles was analyzed as in (A) but using CaCl2 concentrations 
ranging from 0 (1 mm EGTA) to 500 μm. A representative gel is shown 
in (B) and the densitometric analysis is shown in (C; black circles) 
compared to that of AnxA13b (open circles). Data represent mean 
values ± SD of three independent experiments.
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Figure 5: Calcium-dependent changes in the fluorescence emission 
spectra of AnxA13a in the presence of PS liposomes.
(A) Emission spectra at 295 nm excitation wavelength in the absence 
of calcium (1 mm EGTA) or at increasing CaCl2 concentration were 
registered at 20°C in the presence of 50 nm unilamellar vesicles 
using a lipid/protein ratio of 800 : 1 (protein concentration:  
0.05 mg/ml or 1.4 μm). Only spectra at representative calcium 
concentrations are shown. Fluorescence is expressed in arbitrary 
units (a.u.). (B) Variation in the F335/F2321 fluorescence intensity ratio 
of Trp186 and in the position of its emission maximum (inset) with 
calcium concentration.
AnxA13a was quantitatively bound to PS vesicles and 
> 85% to phosphatidylglycerol (PG), but no binding was 
detected to phosphatidylcholine (PC) or raft-like vesicles 
(Figure 4A, lower panels).
A more detailed analysis of the calcium dependence 
of AnxA13a binding to PS vesicles is shown in Figure 4B 
and C. The binding of AnxA13a follows a sigmoidal pattern 
with a midpoint at 58 ± 4 μm CaCl2, slightly higher than 
that described for other annexins as AnxA5 or A11 (around 
20 μm) (Lecona et al., 2003; Turnay et al., 2009; Lizarbe 
et  al., 2013), but much lower than that obtained for the 
long AnxA13b isoform (319 ± 7 μm CaCl2) (Figure 4C).
Binding of AnxA13a to PS membranes was also 
studied by recoding Trp186 fluorescence emission spectra 
of the recombinant protein in the presence of unilamellar 
vesicles (50 nm in diameter) at a constant lipid to protein 
molar ratio (800 : 1) and increasing CaCl2 concentrations 
(Figure 5). The addition of PS vesicles in the absence of 
calcium (1 mm EGTA) did not alter the overall shape of the 
spectrum, which showed a maximum at 321 nm (instead 
of 320  nm in the absence of phospholipids) (Figure 5A). 
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When calcium was sequentially added to the protein/
PS mixture, a shift in Trp186 maximum position towards 
335 nm was first observed with the apparent existence of 
two Trp populations (Figure 5A and B inset). An increase 
in the quantum yield was also observed that reached a 
maximum at CaCl2 concentration above 150 μm. These 
changes also affected the F335/F321 fluorescence ratio, 
which showed a sigmoidal increase with a midpoint at 
29 ± 3 μm CaCl2 quite similar to that observed for the shift 
in the position of the maximum (midpoint at 33 ± 4 μm) 
although the latter showed a sharper transition.
Induction of vesicle aggregation was analyzed using 
PS vesicles at different protein and calcium concentra-
tions. However, no aggregation was induced by the recom-
binant protein even at high protein (2 μm) or calcium 
concentrations (1 mm CaCl2).
Discussion
We have verified that the short AnxA13 isoform is indeed 
expressed in human colorectal adenocarcinoma cells. 
AnxA13a mRNA was detected by RT-PCR in exponentially 
growing HT-29 and Caco-2 cells even without the require-
ment of glucose deprivation as initially described in HT-29 
cells. Both isoforms were detected and, although a quan-
titative analysis was not carried out, mRNA levels were 
quite similar in HT-29 cells and only a slight prevalence 
of AnxA13b mRNA was observed in Caco-2 cells (around 
2-fold). Moreover, protein expression was also detected 
by Western blot and the relative expression levels quali-
tatively agreed with those observed in mRNA. When 
AnxA13a was first reported in HT-29 cells, the mRNA from 
this short isoform was detected as the primary transcrip-
tion product. Our results differ from these original data 
as we detect equal amounts of mRNA from both AnxA13 
isoforms in HT-29 cells in the absence of differentia-
tion-inducing treatments. Wice and Gordon (1992) also 
reported on the lack of AnxA13 mRNA in Caco-2 cells, 
either proliferating or postconfluent. However, here we 
clearly demonstrate that these cells also express AnxA13a 
mRNA and protein, although in a slightly lower extent 
than that corresponding to the long isoform AnxA13b. 
In addition, expression levels are qualitatively similar 
to those expressed by proliferating HT-29 cells. In any 
case, these results do not contradict the potential role 
of AnxA13a in colonocyte differentiation as Caco-2 cells 
are also able to differentiate. On the contrary, they open 
a potential future line of research to analyze whether 
AnxA13a is involved or required for colonocyte differen-
tiation, or if the ratio between both isotypes is somehow 
related or dependent on the proliferative or differentia-
tion stage of the cells.
The structural characterization and analysis of 
the phospholipid binding ability of non-myristoylated 
AnxA13a was carried out with the recombinant protein, 
comparing it with the long isoform previously character-
ized by our group (Turnay et al., 2005), in order to deter-
mine the influence of the 41 amino acid cassette in the 
properties of annexin A13 as well as in calcium binding. 
Purification of recombinant AnxA13a followed a protocol 
quite similar to that described for other members of the 
annexin family due to its affinity for acidic phospholipids 
(Arboledas et al., 1997).
As for the purification of AnxA13b (Turnay et  al., 
2005), the short isoform also required a higher NaCl 
concentration to extract the protein from the vesicles, 
emphasizing the importance of ionic interactions in 
membrane binding (Campos et  al., 1998; Montaville 
et  al., 2002). Circular dichroism of AnxA13a reveals 
that the protein is correctly folded with an overall sec-
ondary structure quite similar to that reported for 
other annexins with a medium/short N-terminus, as 
AnxA5. CCA and other algorithms predict a secondary 
structure with a high α-helical content which has been 
described as a very stable arrangement. In fact, the Tm 
of AnxA13a in the absence of calcium is relatively high 
(around 50°C) and similar to other annexins with short 
N-terminus (Turnay et al., 2002). Interestingly, AnxA13b, 
whose protein core is identical to the short isoform, is 
much less stable with a Tm 6°C lower under equivalent 
experimental conditions (Turnay et al., 2005). This result 
clearly indicates that the longer N-terminal extension 
in AnxA13b, which is predicted as random coil (Turnay 
et al., 2005), can destabilize the protein core. This is not 
the case for other vertebrate annexins with an N-termi-
nus with a similar length, as AnxA1 or AnxA2, whose 
thermal stability is even higher than that of short-tailed 
annexins probably due to the existence of α-helices in 
their N-terminus that strongly interact with the protein 
core in the absence of calcium as described for AnxA1 
(around 60°C) ( Rosengarth et  al., 1999). The difference 
in thermal stability between both annexin A13 isoforms 
probably arises from slight modifications in the protein 
core structure and to the decrease in the overall α-helical 
content of the long isoform due to the destabilizing effect 
of the longer N-terminal extension in AnxA13b (Turnay 
et al., 2005). This fact could contribute to the functional 
differences between annexin A13 isoforms, for example, 
regarding the interaction with membranes via the 
convex core surface where the calcium and phospholipid 
binding domains are localized.
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Saturation of AnxA13a with calcium did not sig-
nificantly alter the CD spectrum of the protein, but it 
did strongly affect thermal stability in a concentration-
dependent manner; the Tm of the protein increases 10°C. 
Thus, although the overall secondary structure of this 
annexin is mainly unaltered, changes in the loops con-
necting α-helices in the calcium binding regions of the 
convex surface must occur, as reported for other members 
of the annexin superfamily, that reinforce the stability of 
the protein core. These changes are clearly observed when 
the fluorescence emission spectra of the only Trp residue 
of the molecule is analyzed. Trp186 is in a position equiva-
lent to Trp187 in annexin A5 according to sequence align-
ment and to the 3D-model that we previously reported for 
the AnxA13 protein core (Turnay et al., 2005) (Figure 6). 
In the absence of calcium, the position of the trypto-
phan emission maximum is 320  nm, which corresponds 
to a residue protected from the environment. This is in 
good agreement with the acrylamide quenching experi-
ments in the absence of calcium that yield a low Stern-
Volmer constant (3.15 m−1), quite similar to that reported 
for the long isoform (2.99 m−1) and only slightly higher 
Figure 6: Three-dimensional model of annexin A13a.
Three-dimensional protein models of human AnxA13a in the absence (w/o Ca2+) or in the presence (with Ca2+) of calcium were obtained as 
described previously (Turnay et al., 2005) using the Swiss-Model Server. (A) Three-dimensional structure of domain III of human AnxA5 (resi-
dues 167–246) in the absence of calcium bound to this domain (‘closed’ conformation; PDB entry: 1AVH). Dotted lines and green shading 
mark hydrogen bonds responsible for static quenching of W187 fluorescence emission. Helices A to E are indicated. (B) Three-dimensional 
protein model of domain III of AnxA13a (residues 166–245) in the absence of calcium, and (C) in the ‘high-calcium’ form. (D) Full three-
dimensional model predicted for AnxA13a in the presence of calcium. Left: van der Walls surface representation showing negatively charged 
(red), positively charged (blue) or hydrophobic surfaces. Right: ribbon representation showing the four protein domains in different colors 
as well as the main calcium binding regions (shadowed in yellow) with indication of the residues or carbonyl oxygen atoms potentially 
involved in calcium chelation. Hydrophobic residues protruding from the loops between helices A and B in the four domains are shown. The 
figure was prepared using the MOLMOL program (Koradi et al., 1996).
S. Fernández-Lizarbe et al.: Characterization of annexin A13a   367
than that for human (0.39 m−1) (Sopkova et al., 1998) and 
chicken (1.94  m−1) (Arboledas et  al., 1997) AnxA5. These 
data strongly support the notion that Trp186 in buried in 
a hydrophobic cleft when AnxA13a is in the calcium-free 
or ‘closed’ conformation as suggested by the 3D model 
(Figure 6B). Upon calcium binding, the environment of 
the Trp residue changes dramatically according to the 
modifications observed in the fluorescence emission 
spectra: a 24  nm red-shift and a significant increase in 
the quantum yield. The red-shift in the fluorescence emis-
sion maximum of Trp186 clearly indicates that it changes 
to an exposed environment; this fact is confirmed by the 
increased accessibility of acrylamide to this residue, with 
a high Stern-Volmer constant (12.84 m−1) that corresponds 
to an almost completely exposed Trp residue (Lakow-
icz, 2006) and is again in agreement with the proposed 
structural model (Figure 6C). The quantum yield of a Trp 
residue exposed to the polar solvent should decrease due 
to dynamic quenching. However, AnxA13a behaves differ-
ently showing an increase in the quantum yield of Trp186 
when it is exposed. A similar effect has been described 
for annexin A5 and has been attributed to the existence of 
static quenching of the Trp fluorescence due to the estab-
lishment of hydrogen bonds between the nitrogen atom of 
the indole ring and the hydroxyl and carbonyl oxygens of 
a threonine residue located in the loop between helices 
D and E in domain III of annexin A5 (Thr224) (Sopkova-De 
Oliveira Santos et al., 2001) (Figure 6A). AnxA13a does not 
have a threonine residue in an equivalent position but, 
as observed in the 3D model structure of the protein core 
of AnxA13 (Turnay et al., 2005) (Figure 6B), this position 
is occupied by an alanine residue (Ala264 in AnxA13b and 
Ala223 in AnxA13a) whose carbonyl oxygen is at the right 
distance and orientation to establish a hydrogen bond 
with the indole ring of Trp186.
Interestingly, changes in the environment of the Trp 
residue take place at lower calcium concentrations than 
those required for the overall structural/thermal stabi-
lization. The midpoint concentration for the red-shift in 
the Trp emission maximum is 1.1 mm (2.5 mm for F344/F320) 
whereas the midpoint for the increase in the Tm is around 
20 mm. This difference in calcium requirements strongly 
suggests that calcium may bind not only to the canonical 
type II calcium-binding domains located in the AB loops 
in each domain of AnxA13a (as suggested by the sequence 
alignment and the 3D-model; Figure 6D), but that addi-
tional calcium binding sites with lower affinity for this 
cation may also exist, as described in other vertebrate 
annexins, contributing not only to stabilize the annexin 
core but also increase the affinity for acidic phospholipids 
(Lizarbe et al., 2013).
As observed from the fluorescence emission spectra 
of AnxA13b in the presence of PS vesicles, the conforma-
tional change affecting the AB loop where Trp186 is located 
is required for the interaction. The spectra under these 
conditions also experiments a red-shift with an increase 
in the quantum yield in a calcium-dependent manner. 
But this changes take place at calcium concentrations 
two orders of magnitude lower than in the absence of PS 
vesicles (around 30 μm). The red-shift is 10  nm smaller 
than that observed in the absence of PS probably due to 
a partial protection of Trp186 from the polar solvent as this 
residue is partially inserted into the phospholipid bilayer; 
this could also explain the higher increase in the quantum 
yield upon interaction of AnxA13a with PS vesicles in the 
presence of calcium.
Experiments with MDCKII cells transfected with 
recombinant myristoylated and non-myristoylated 
AnxA13 isoforms clearly indicate that the myristoyl moiety 
is required for their association with lipid rafts which are 
mainly present in the apical membranes (Lecat et  al., 
2000). However, binding of AnxA13 to rafts requires not 
only myristoylation, but also calcium. In fact, Lafont and 
coworkers (Lafont et al., 1998) have reported that only half 
of the cellular pool of AnxA13b is bound to membranes 
when calcium is chelated. In agreement with this obser-
vation, we have described that, in vitro, myristoylated 
AnxA13b (but not the non-myristoylated form) partially 
binds to raft-like liposomes and to neutral or acidic phos-
pholipids in the absence of calcium, but requires calcium 
for quantitative binding (Turnay et  al., 2005). This is 
probably due to the weak interaction between myris-
toylated proteins and lipid bilayers, which show a Gibbs 
free binding energy of around 8 kcal/mol (Peitzsch and 
McLaughlin, 1993). Hence, binding of AnxA13 isoforms to 
rafts may require additional calcium-dependent interac-
tions between the convex side of the protein core (where 
calcium-binding sites are located; Figure 6D) with the 
membranes either directly or through interactions with 
other membrane-bound proteins. In addition, as shown in 
Figure 6D, the convex surface of the calcium-bound con-
formation of both isoforms presents hydrophobic residues 
protruding from the loops between helices A and B in each 
domain (M30, L102, W186 and A261 in AnxA13a), which could 
contribute to strengthening binding to membranes.
In contrast to the subcellular localization of AnxA13b, 
which is only found associated to raft-like structures in 
the apical membrane of MDCKII cells, AnxA13a can be 
found not only in apical membrane domains, but also in 
the basolateral membranes of polarized epithelial cells. 
Myristoylation of AnxA13a is required for its apical deliv-
ery as transfection of MDCKII cells with non-myristoylated 
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AnxA13a showed that this mutant protein did not interact 
with lipid rafts, although it bound in a calcium-depend-
ent manner to basolateral membranes (Lecat et al., 2000). 
Thus, binding to non-raft membranes in vivo (as the baso-
lateral membranes of epithelial cells) probably does not 
take place via the N-myristoylated tail but only through 
the calcium and phospholipid binding sites located in the 
convex side of the protein core. Our data suggest that the 
different subcellular distribution of both AnxA13 isoforms 
is probably due to their significant differences regarding 
calcium requirements for binding to the acidic phospho-
lipids present in the inner leaflet of basolateral mem-
branes. Consequently, the high calcium concentrations 
required by AnxA13b would direct this isoform almost 
exclusively towards raft-containing vesicles that migrate 
apically.
The affinity of purified non-myristoylated AnxA13a for 
phospholipid vesicles reveals that this protein only inter-
acts with acidic phospholipids (but not with PC or raft-like 
liposomes) in a calcium-dependent manner. As AnxA13a 
shows a relatively low calcium-requirement for binding to 
acidic membranes (similar to those of AnxA5), it may bind 
to non-raft containing vesicles directed towards the baso-
lateral epithelial membrane, whereas this is not possible 
for the long isoform. In vitro binding requires calcium con-
centration in the low micromolar range, which would be 
higher than basal cytosolic free calcium (around 100 nm). 
However, one has to take into account that lipid com-
position in the secretory vesicles is more complex and 
also that protein-protein interactions may facilitate the 
process. In addition, as shown in Supplementary Figure 3, 
stimulation of epithelial cells produces localized calcium 
domains around the Golgi or the basolateral plasma mem-
brane (Leipziger et  al., 1996; Hofer, 2005; Dolman and 
Tepikin, 2006; Pizzo et  al., 2011), which could facilitate 
the binding of AnxA13a to these membranes (although not 
being high enough for the binding of non-myristoylated 
AnxA13b).
In summary, the structural and phospholipid-bind-
ing characterization of AnxA13a has revealed that this 
AnxA13 short isoform is quite different both in structure 
and behavior compared to long AnxA13b. Interestingly, 
recombinant non-myristoylated AnxA13a is quite similar 
to annexin A5 regarding secondary structure, thermal sta-
bility, and calcium requirements for membrane binding. 
Surprisingly, even though the protein core of both iso-
forms of AnxA13 are identical in sequence, the extra 41 
amino acids in the N-terminus of AnxA13b must be inter-
fering with the phospholipid binding sites in the convex 
surface of the molecule. There is a huge difference in the 
calcium requirements for binding to PS vesicles between 
both isoforms which could account for their different sub-
cellular localization.
Materials and methods
Protein expression and purification
The human AnxA13a expression construct pTrcA13Ha was a generous 
gift from Prof. M.P. Fernández and Dr. R.O. Morgan from the University 
of Oviedo (Spain). The encoding region of the cDNA (NM_004306) was 
inserted between NcoI and HindIII restriction sites of the expression 
vector pTrc99A (Amersham Biosciences, Barcelona, Spain) and the 
identity of the construct was verified by DNA restriction analysis and 
sequencing. JA221 E. coli cells were transformed with the expression 
construct pTrcA13Ha and grown in LB broth containing 100 μg/ml of 
ampicillin at 37°C until an OD600 of 0.5. Different induction times and 
temperatures after addition of 0.5 mm isopropyl β-D-thiogalactoside 
(IPTG) were studied. Protein production was high at short induction 
times at 37°C and recombinant AnxA13a was detectable by SDS-PAGE 
and Coomassie blue staining. Longer times did not increase the pro-
tein yield significatively; thus, 3 h induction at 37°C was chosen as the 
optimal conditions for protein expression. Purification of the recom-
binant protein was achieved taking advantage from the property of 
being able to reversibly interact with PS vesicles and following, with 
slight modifications, the method described for annexin A5 (Arbole-
das et al., 1997) and A13b (Turnay et al., 2005). The electrophoretic 
and Western blot analyses of the material from the main steps of the 
purification process are shown in Supplementary Figure 2A. Briefly, 
after centrifugation at 6000 g for 15 min, collected cells were resus-
pended in 50 mm Tris, pH 7.4, containing 0.1 m NaCl, 2.5 mm EGTA and 
2 mm PMSF and ruptured by sonication cycles at 4°C (lane H). The 
homogenate was stirred at 4°C for 90 min and centrifuged at 27 000 g 
for 90 min at 4°C, allowing the solubilization of the recombinant pro-
tein with a high yield (lane S0). The supernatant was mixed with PS-
enriched vesicles (1 mg/ml final concentration; Sigma, Alcobendas, 
Spain) and 2 mm CaCl2, and stirred for 30 min at 4°C. The mixture was 
centrifuged at 27 000 g for 45 min at 4°C; the main part of the bacte-
rial proteins remained in the supernatant (lane S1). The vesicle pellet 
was washed twice with 50 mm Tris, pH 7.4, containing 0.1 m NaCl and 
2 mm CaCl2. The recombinant protein was then extracted by resuspen-
sion of the vesicles in the presence of 50 mm Tris, pH 7.4, containing 
5 mm EGTA and 0.25 m NaCl and further centrifugation (lane E). At 
this step, a major protein contaminant of around 45  kDa was still 
present together with unsedimented phospholipidic vesicles. Finally, 
the protein was purified first by DEAE-cellulose chromatography, 
after dialysis against 50 mm Tris, pH 7.4, 1 mm EGTA, and elution of 
AnxA13a using a linear NaCl gradient, and second by size-exclusion 
chromatography on a Sephadex G-75 column (Amersham Pharmacia 
Biotech, Buckhinghamshire, UK). Purified protein (lane A13a) was 
dialyzed versus 20 mm Hepes, pH  7.4, containing 0.1 m NaCl, and 
concentrated, when required, using Vivaspin centrifugal concentra-
tors with a 10 000 Da molecular weight cut-out (Sartorius, Göttingen, 
Germany). Purification of AnxA5 and AnxA13b for comparative pur-
poses was carried out in our laboratory according to the previously 
described protocols (Arboledas et al., 1997; Turnay et al., 2005).
The identity of the recombinant protein (AnxA13a) was con-
firmed by amino acid analysis (Beckman 6300 amino acid analyzer) 
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as well as N-terminal sequencing (12 residues) and MALDI-TOF MS 
(matrix-assisted laser-desorption ionization time-of-flight mass 
spectroscopy), as previously described (Turnay et  al., 2005) (Sup-
plementary Figure 2B). The molar absorption coefficient of AnxA13a 
at 280 nm was determined from the UV-visible spectra after subtrac-
tion of apparent absorption due to light scattering and determination 
of the protein concentration by amino acid analyses from aliquots 
directly taken from the cuvette (E0.1% = 0.75).
Circular dichroism spectroscopy
The far-UV CD spectra were monitored between 200 and 250 nm at 
20°C in a Jasco J-715 spectropolarimeter equipped with a Neslab RTE-
111 thermostat using 0.05  cm pathlength thermostatized cuvettes. 
Melting curves were obtained in 20 mm Hepes, pH 7.4, containing 
0.1 m NaCl to avoid pH changes during heating. Changes in elliptic-
ity at 208 nm were monitored between 20 and 80°C at 60°C/h. The 
effect of calcium on the far-UV CD spectrum and Tm was analyzed 
by employing protein samples with increasing CaCl2 concentrations. 
Samples with equivalent maximal ionic strength, obtained by addi-
tion of NaCl or MgCl2 instead of CaCl2, were used as controls. Control 
samples without calcium always contained 1 mm EGTA. All spectra 
were averaged over six scans and were corrected by subtracting buffer 
contribution from parallel spectra in the absence of protein; units are 
expressed as mean residue weighed molar ellipticities ([θ]MRW). Pre-
diction of the secondary structure from the far-UV CD spectra was 
performed using the convex constraint algorithm (CCA) as described 
by Perczel and coworkers (Perczel et al., 1992).
Fluorescence emission spectroscopy
Fluorescence emission spectra were recorded in an SLM Aminco 
8000C spectrofluorimeter at 20°C. Trp emission was measured using 
an excitation wavelength of 295 nm in a 0.4 cm excitation pathlength 
and 1.0  cm emission pathlength cuvette. Spectra were monitored 
between 285 and 400 nm. Rayleigh scattering at 90° was obtained 
from the maximum at 295 nm of spectra recorded at this excitation 
wavelength. The effect of calcium was titrated by sequential addition 
of CaCl2. Acrylamide quenching of Trp fluorescence was analyzed 
by recording emission spectra (295  nm excitation wavelength) at 
increasing acrylamide concentrations, and taking into account the 
effect of dilution as previously described (Lecona et al., 2003; Turnay 
et al., 2005). Care was taken to avoid the inner filter effect and that 
solutions presented always UV absorption below 0.04 at 295 nm. The 
quenching constant (KSV) was calculated from the Stern-Volmer plot 
of F0/F at the emission maximum against acrylamide concentration, 
according to the equation F0/F = 1 + KSV[Q], where F0 is the fluores-
cence intensity at zero quencher concentration and F the intensity at 
a given quencher concentration ([Q]).
Binding to phospholipids and vesicle aggregation  assays
Unilamellar vesicles of PS (Avanti Polar Lipids, Alabaster, AL, USA), 
phosphatidylcholine (PC), phosphatidylglycerol (PG), and a raft-like 
mixture (PC : sphingomyelin : cholesterol 1 : 1 : 1) (all from Sigma 
except  PS) were obtained by hydration of a thin dried-lipid film in 
20 mm Hepes, pH 7.4, containing 0.1 m NaCl, followed by extrusion 
through polycarbonate filters of 100 or 400 nm pore diameter (Lipex 
Biomembranes, Vancouver, Canada). Small unilamellar vesicles 
(50  nm) were prepared from freshly obtained 400  nm vesicles by 
further extrusion through polycarbonate filters of the corresponding 
pore diameter.
The interaction of AnxA13a with 400  nm vesicles was carried 
out at a constant lipid/protein molar ratio of 800 : 1 with variable cal-
cium concentrations in 20 mm Hepes, pH 7.4, containing 0.1 m NaCl 
at 20°C for 15 min. The final mixture (100 μl) was ultracentrifuged 
at 150 000 g and 4°C for 1 h (Optima Max-XP ultracentrifuge with a 
TLA 120.1 rotor; Beckman-Coulter, Brea, CA, USA). After separation 
of supernatant and pellet, protein was detected by Coomassie blue 
staining after SDS-PAGE. Phospholipid-free controls showed negligi-
ble sedimentation of annexin under these experimental conditions. 
Gels were scanned in a Gel Doc XR system from Bio-Rad (Alcobendas, 
Spain) and a densitometric analysis was performed, obtaining volu-
mograms, using the QuantityOne v4.6.9 software.
Vesicle aggregation studies were carried out by recording 
absorption at 360 nm immediately after the addition of calcium to a 
mixture of unilamellar vesicles (100 nm; 0.1 mg/ml) and AnxA13a at 
25°C. Calcium was added from a CaCl2 stock solution, and absorption 
was registered in a thermostatically controlled cuvette for at least 
10 min.
Cell culture, RT-PCR and Western blotting
Caco-2 (HTB-37) and HT-29 (HTB-38) human colorectal adenocar-
cinoma cells were obtained from the ATCC (American Type Culture 
Collection) and were cultured in DMEM (Dulbecco’s modified Eagle’s 
medium) containing 4.5 g/l glucose and supplemented with 10% 
heat-inactivated fetal calf serum, penicillin (100 IU/ml), streptomy-
cin (100 μg/ml) and 2 mm glutamine. Cells were maintained in a 
humidified atmosphere of 5% CO2 at 37°C and were routinely subcul-
tured by trypsinization (0.05% trypsin, 0.02% EDTA).
RT (reverse transcriptase)-PCR analysis was carried out using 
total RNA isolated from exponentially growing cells using the 
ToTALLY RNA kit and the RETROscript RT-PCR kit, both from Ambion 
(Austin, TX, USA). The quality of the purified RNA was verified using 
a 2100 Bioanalyzer from Agilent (Santa Clara, CA, USA). PCR reac-
tions were carried out in a GeneAmp PCR Sysytem (Applied Biosys-
tems, Alcobendas, Spain) using the same amount of RT-template, 
AmpliTaq Gold PCR Master Mix (Invitrogen, Alcobendas, Spain) and 
primer pairs designed specifically for the amplification of AnxA13a, 
AnxA13b, both annexin isoforms simultaneously or GAPDH as con-
trol (Lecona et al., 2008) (Supplementary Figure 1).
Total cell protein extracts were obtained by solubilization of the 
monolayers in lysis buffer (10 mm Tris pH 8.0, 140 mm NaCl and 2% 
Triton X-100) containing protease inhibitors (Santiago-Gómez et al., 
2013). Cell lysates were resolved by SDS-PAGE after heat denaturing 
in presence of 5% β-mercaptoethanol. Proteins were transferred to 
nitrocellulose membranes and analyzed by Western blot as described 
elsewhere (Lecona et al., 2003) using rabbit polyclonal anti-human 
AnxA13b or mouse monoclonal anti human vinculin (hVIN1, Sigma) 
antibodies followed by the corresponding secondary anti-rabbit IgG-
HRP (Bio-Rad) or anti-mouse IgG-HRP (Pierce/Thermo Scientific, 
Rockford, IL, USA). Vinculin was used as protein loading control. 
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Polyclonal antibodies against recombinant human AnxA13b, that 
recognize both isoforms ‘a’ and ‘b’, were obtained as previously 
described (Turnay et al., 2005). 
Other procedures
Protein concentration in pure preparations was determined from the 
UV-visible spectra, except for CD spectroscopy, where quantitative 
amino acid analysis was used. In cell extracts, protein concentration 
was determined using the DC Protein assay (Bio-Rad). The struc-
tural three-dimensional models of AnxA13a in the calcium-bound 
and unbound states were obtained using the Swiss-Model server as 
described previously (Turnay et al., 2005). Regression fitting of the 
experimental data to different equations and statistical analyses 
were performed using SigmaPlot software v.13 (Systat Software, San 
Jose, CA, USA).
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